Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm: CANTA) today announced that Damian Marron, Interim CEO, will participate ...

HC Wainwright reissued their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a research note ...

HC Wainwright reaffirmed their buy rating on shares of Foghorn Therapeutics (NASDAQ:FHTX – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $13.00 ...

Fintel reports that on March 7, 2025, HC Wainwright & Co. initiated coverage of Surf Air Mobility (NYSE:SRFM) with a Buy ...

Fintel reports that on March 6, 2025, HC Wainwright & Co. initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy ...

Our analysis of options history for SpringWorks Therapeutics SWTX revealed 9 unusual trades. Delving into the details, we ...

H.C. Wainwright analyst Amit Dayal initiated coverage of Surf Air Mobility (SRFM) with a Buy rating and $12 price target The firm views Surf ...

H.C. Wainwright notes that Neutral-rated Cassava Sciences (SAVA) has announced its financial and operational results for the fiscal year ended December 31, 2024. The firm views the company’s licensing ...

H.C. Wainwright lowered the firm’s price target on Repare Therapeutics (RPTX) to $5 from $10 and keeps a Buy rating on the shares following the ...

H.C. Wainwright analyst initiates coverage on Surf Air Mobility Inc. with a Buy rating and $12 price target, citing potential ...

Plug Power (Nasdaq: PLUG). From a high north of $3, shares of the hydrogen pioneer have been cut roughly in half, falling as ...

Ten companies across mixed sectors also mirrored a broader market optimism, booking modest gains during the end of the ...